Your browser doesn't support javascript.
loading
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Glintborg, Bente; Loft, Anne Gitte; Omerovic, Emina; Hendricks, Oliver; Linauskas, Asta; Espesen, Jakob; Danebod, Kamilla; Jensen, Dorte Vendelbo; Nordin, Henrik; Dalgaard, Emil Barner; Chrysidis, Stavros; Kristensen, Salome; Raun, Johnny Lillelund; Lindegaard, Hanne; Manilo, Natalia; Jakobsen, Susanne Højmark; Hansen, Inger Marie Jensen; Dalsgaard Pedersen, Dorte; Sørensen, Inge Juul; Andersen, Lis Smedegaard; Grydehøj, Jolanta; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund.
Afiliación
  • Glintborg B; The DANBIO registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Glostrup, Denmark glintborg@dadlnet.dk.
  • Loft AG; Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Omerovic E; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Hendricks O; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Linauskas A; Department of Rheumatology, Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, København, Denmark.
  • Espesen J; Kong Christian X's Gigthospital, Gråsten, Denmark.
  • Danebod K; Department of Rheumatology, North Denmark Regional Hospital, Hjørring, Denmark.
  • Jensen DV; Department of Rheumatology, Vejle Hospital, Vejle, Denmark.
  • Nordin H; Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Dalgaard EB; Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Chrysidis S; Department of Rheumatology, Zealand University Hospital, Køge, Denmark.
  • Kristensen S; Department of Rheumatology, Silkeborg Hospital, Silkeborg, Denmark.
  • Raun JL; Department of Rheumatology, Esbjerg Hospital, Esbjerg, Denmark.
  • Lindegaard H; Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark.
  • Manilo N; Department of Rheumatology, Sygehus Lillebælt, Fredericia, Denmark.
  • Jakobsen SH; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
  • Hansen IMJ; Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Denmark.
  • Dalsgaard Pedersen D; Department of Rheumatology, OUH, Svendborg Hospital, Svendborg, Denmark.
  • Sørensen IJ; Department of Rheumatology, OUH, Svendborg Hospital, Svendborg, Denmark.
  • Andersen LS; Department of Rheumatology, OUH, Svendborg Hospital, Svendborg, Denmark.
  • Grydehøj J; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Mehnert F; Department of Internal Medicine, Rønne Hospital, Rønne, Denmark.
  • Krogh NS; Department of Rheumatology, Holstebro Hospital, Holstebro, Denmark.
  • Hetland ML; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Ann Rheum Dis ; 79(2): e14, 2020 02.
Article en En | MEDLINE | ID: mdl-30573653
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antirreumáticos / Biosimilares Farmacéuticos Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antirreumáticos / Biosimilares Farmacéuticos Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article